Identification of G-proteins coupling to the vasoactive intestinal peptide receptor VPAC1 using immunoaffinity chromatography:: Evidence for precoupling

被引:15
作者
Shreeve, SM [1 ]
机构
[1] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA
关键词
vasoactive intestinal peptide; vasoactive intestinal peptide receptor; human VPAC(1); G-protein; receptor signaling; receptor/G-protein coupling; precoupling; immunoaffinity chromatography; cross-linking;
D O I
10.1006/bbrc.2002.6342
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
VPAC(1) receptor subtype-specific G-protein interactions were identified using a strategy that exploits an essential initial signaling event, namely the functional and physical association of the receptor with G-protein. An immunoaffinity purification column was constructed using a previously characterized antibody that had been raised against the first extracellular loop of the VPAC(1) receptor. VPAC(1)/G-protein complexes were solubilized from membranes and copurified. Receptor and Galpha-proteins were detected in eluates using I-125-VIP labeling and immunoblotting, respectively. Human VPAC(1) transfected in HEK293 cells couples to Gs but not Gi3, Gi1/2, or Gq. Rat VPAC(1) in brain membranes is coupled to Gs and Gi3. Rat VPAC(1) in lung membranes couples to Gs, Gi3, and Gq. Pretreatment of membranes with VIP increased the level of all G-proteins copurifying with VPAC(1). Immunoaffinity chromatography also revealed VPAC(1) receptor precoupling to G-protein in the absence of VIP pretreatment. This was confirmed using a cross-linking procedure to capture VIP receptor/G-protein complexes in the native membrane milieu prior to solubilization. Precoupling suggests that there is a significant basal level of VPAC(1) receptor activity especially in cells, such as some human malignant tumor cells, that express high levels of receptor. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:1300 / 1307
页数:8
相关论文
共 52 条
[1]   Gq/11 and Gi/o activation profiles in CHO cells expressing human muscarinic acetylcholine receptors:: dependence on agonist as well as receptor-subtype [J].
Akam, EC ;
Challiss, RAJ ;
Nahorski, SR .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (04) :950-958
[2]   How receptors talk to trimeric G proteins [J].
Bourne, HR .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :134-142
[3]   Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung [J].
Busto, R ;
Prieto, JC ;
Bodega, G ;
Zapatero, J ;
Carrero, I .
PEPTIDES, 2000, 21 (02) :265-269
[4]   Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery [J].
de Ligt, RAF ;
Kourounakis, AP ;
Ijzerman, AP .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :1-12
[5]   Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease [J].
Delgado, M ;
Abad, C ;
Martinez, C ;
Laceta, J ;
Gomariz, RP .
NATURE MEDICINE, 2001, 7 (05) :563-568
[6]   Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of fas ligand in activated T lymphocytes by regulating c-myc, NF-κB, NF-AT, and early growth factors 2/3 [J].
Delgado, M ;
Ganea, D .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :1028-1040
[7]   VIP and PACAP: very important in pain? [J].
Dickinson, T ;
Fleetwood-Walker, SM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (08) :324-329
[8]  
Diehl NL, 1996, MOL PHARMACOL, V50, P624
[9]   Aspects on the pathophysiology of migraine and cluster headache [J].
Edvinsson, L .
PHARMACOLOGY & TOXICOLOGY, 2001, 89 (02) :65-73
[10]   TRANSMITTER ROLE OF VASOACTIVE-INTESTINAL-PEPTIDE [J].
FAHRENKRUG, J .
PHARMACOLOGY & TOXICOLOGY, 1993, 72 (06) :354-363